We are live on ! Find out more
CK

Cohen Klingenstein Portfolio holdings

AUM $3.49B
1-Year Est. Return 26.65%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.7%
5 Year Est. Return
+104.29%
10 Year Est. Return
+422.19%
AUM
$2.87B
AUM Growth
+$115M
Cap. Flow
-$19.6M
Cap. Flow %
-0.68%
Top 10 Hldgs %
52.63%
Holding
223
New
1
Increased
4
Reduced
38
Closed
3

Top Buys

Rank Stock Value
1
STT icon
State Street
STT
+$219K
2
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$26K
3
VOT icon
Vanguard Morningstar Mid-Cap Growth ETF
VOT
+$21K
4
BAC icon
Bank of America
BAC
+$80
5
PFE icon
Pfizer
PFE
+$58

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$6.24M
2
MSFT icon
Microsoft
MSFT
+$3.42M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$1.34M
4
SHEL icon
Shell
SHEL
+$1.15M
5
HIG icon
Hartford Financial Services
HIG
+$959K

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 9.89%
3 Healthcare 9.72%
4 Communication Services 8.54%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
101
Citigroup
C
$222B
$3.09M 0.11%
49,300
– –
OTIS icon
102
Otis Worldwide
OTIS
$27.3B
$3.05M 0.11%
29,307
– –
PGR icon
103
Progressive
PGR
$124B
$3.05M 0.11%
12,000
– –
GILD icon
104
Gilead Sciences
GILD
$163B
$2.99M 0.1%
35,700
– –
ADP icon
105
Automatic Data Processing
ADP
$105B
$2.96M 0.1%
10,705
– –
SBUX icon
106
Starbucks
SBUX
$121B
$2.93M 0.1%
30,100
– –
NKE icon
107
Nike
NKE
$62.7B
$2.87M 0.1%
32,500
– –
VRTX icon
108
Vertex Pharmaceuticals
VRTX
$122B
$2.79M 0.1%
6,000
– –
SPGI icon
109
S&P Global
SPGI
$122B
$2.79M 0.1%
5,400
– –
TJX icon
110
TJX Companies
TJX
$176B
$2.77M 0.1%
23,600
– –
INTC icon
111
Intel
INTC
$460B
$2.71M 0.09%
115,400
– –
EPI icon
112
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$2.7M 0.09%
53,600
– –
GEN icon
113
Gen Digital
GEN
$16.3B
$2.7M 0.09%
98,600
– –
GLW icon
114
Corning
GLW
$116B
$2.64M 0.09%
58,580
-3,800
-6% -$160K
CB icon
115
Chubb
CB
$135B
$2.63M 0.09%
9,120
– –
MO icon
116
Altria Group
MO
$113B
$2.63M 0.09%
51,448
– –
BSX icon
117
Boston Scientific
BSX
$68.4B
$2.56M 0.09%
30,500
– –
DE icon
118
Deere & Co
DE
$162B
$2.5M 0.09%
6,000
– –
PLD icon
119
Prologis
PLD
$136B
$2.34M 0.08%
18,500
– –
SYK icon
120
Stryker
SYK
$133B
$2.31M 0.08%
6,400
– –
MDLZ icon
121
Mondelez International
MDLZ
$80.5B
$2.29M 0.08%
31,097
– –
CI icon
122
Cigna
CI
$76.1B
$2.29M 0.08%
6,600
– –
MS icon
123
Morgan Stanley
MS
$330B
$2.27M 0.08%
21,800
– –
MRSH
124
Marsh
MRSH
$91.4B
$2.23M 0.08%
10,000
– –
GEV icon
125
GE Vernova
GEV
$262B
$2.08M 0.07%
8,143
– –
3 4
5
6 7

Similar funds

DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Cohen Klingenstein's Q3 2024 Portfolio in Review

As of Q3 2024, Cohen Klingenstein held 223 positions worth $2.87B, up 4.2% from $2.76B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 1.8%. Cohen Klingenstein opened 1 new position and exited 3, leaving the 223-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Cohen Klingenstein's largest Q3 2024 buy was State Street: 2,650 shares worth $234K.
  • Cohen Klingenstein added most to Vanguard Morningstar Growth ETF in Q3 2024, an estimated $26K increase.
  • Cohen Klingenstein's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.24M.
  • Cohen Klingenstein fully exited Novartis in Q3 2024, selling an estimated $639K.
  • Cohen Klingenstein's ten largest holdings make up 53% of its $2.87B portfolio in Q3 2024.
  • Cohen Klingenstein opened 1 new position and closed 3 in Q3 2024.
  • Cohen Klingenstein's portfolio value rose 4.2% quarter-over-quarter to $2.87B.

Based on Cohen Klingenstein's 13F filing for Q3 2024, filed 16 Oct 2024.